Impacting the Opioid Crisis: Prevention, Education, and Practice for Non-Prescribing Providers
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
Below are links provided to course material for this activity using two learning platforms for your convenience. The educational material is identical.Link to EdX Course Material
Link to Coursera Course Material
- Understand what opioids are and how they work.
- Understand alternatives (non-opioid) treatments for pain.
- Give examples of cutting edge research at U-M that can impact the safe use of opioids and/or treating pain.
- List appropriate strategies for safely disposing of unused opioids.
- Describe accurate prevention/intervention messaging.
- Understand different aspects of public policy that can impact the opioid epidemic.
This activity was released in October 2019, with credit available through September 2022. Continuation of credit from that date depends on a thorough review of the content currency and accuracy.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®. This activity contributes to the CME component of the American Board of Anesthesiology's redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Patrick Carter, MD
Rebecca M Cunningham, MD
Michael Englesbe, MD
Donovan T Maust, MD - University of Michigan
Afton L Hassett, Psy.D.
Pooja AGGARWAL Lagisetty, M.D.
Goodarz M Golmirzaie, MD
Stephen Strobbe, PhD, PhD, RN, PMHCNS-BC, CARN-AP, FIAAN, FAAN
Rebecca L Haffajee, PhD, JD, MPH
Jason Goldstick, PhD
Michael Andrew Smith, PharmD - University of Michigan
Gina Dahlem, PhD, MS - University of Michigan - Ann Arbor
Maureen Welch-Marahar, MPP
Chad MICHAEL Brummett, M.D.
Daniel J Clauw, MD
Paul EDWARD Hilliard, MD
Mark Andrew Ilgen, PhD - University of Michigan
Philip Veliz, PhD
Golfo K Tzilos Wernette, PHD
Romesh P Nalliah, DDS MHCM
Lewei Lin, M.D.
Jenifer J Martin, JD
John Z. Ayanian, MD, MPP - Institute for Healthcare Policy and Innovation
Trish Meyer, Ed.M. - U-M Institute for Healthcare Policy & Innovation
Sarah Anne Stoddard, PhD, CNP, RN
Monica Walker, BA, BSN, MSA - Michigan OPEN
Karen B Farris, PhD
Chad Brummett, MD
- Consultant/Advisory Role|Honoraria / Travel / Speaker Fee for Heron Therapeutics
- Consultant/Advisory Role|Expert Witness for Pfizer, Inc.
- Other - Expert Witness: State of Oklahoma
- The Prescription Opioid and Heroin Crisis - Annual Review of Public Health Vol. 36:559-574 (Volume publication date March 2015)
- Vermont Hub-and-Spoke Model of Care For Opioid Use Disorder:Development, Implementation, and Impact - J Addict Med. Author manuscript; available in PMC 2017 July 31.
- Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52–e59. doi:10.2105/AJPH.2013.301709